Korean Stock Flows

Olix Pharmaceuticals (KRX: 226950)

올릭스 KOSDAQ Biotech & Pharma 자연과학 및 공학 연구개발업
Close (Oct 16, 2026)
₩98,000
+12.26%
Market cap
₩2T ($1.7B)
52-week range
₩84,000 – ₩217,000
P/E (trailing) · P/B · Div yield
– · 14.54 · 0%

Who is buying Olix Pharmaceuticals?

Between Sep 15, 2026 and Oct 16, 2026 (20 trading sessions), foreign investors net sold ₩31.9bn ($24M) of Olix Pharmaceuticals, the 16th largest foreign net sale among 1828 KOSDAQ stocks. Institutions net bought ₩61.2bn ($45M) and retail investors net sold ₩22.7bn ($17M) over the same window. Foreigners were net buyers on 8 of the 20 sessions.

Foreign investors hold 9.49% of Olix Pharmaceuticals' listed shares (KRX ownership data as of Oct 16, 2026), down from 10.93% twenty sessions earlier and 6.07% a year ago.

The stock closed at ₩98,000 on Oct 16, 2026: -2.10% over 20 sessions, -30.20% year-to-date, +9.74% over one year. The 52-week range is ₩84,000 – ₩217,000.

Olix Pharmaceuticals share price, last 60 trading days (KRW)
140,830 121,977 103,123 84,270 Jul 16 Aug 31 Oct 16
Daily foreign investor net purchases, last 60 trading days
+14.8bn +7.4bn -7.4bn -14.8bn Jul 16 Aug 31 Oct 16
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-16 ₩98,000 +₩2.3bn +₩3.7bn ₩-6.2bn
2026-10-15 ₩87,300 ₩-1.5bn +₩2.8bn ₩-0.6bn
2026-10-14 ₩91,300 ₩-0.2bn ₩-5.2bn +₩4.4bn
2026-10-13 ₩91,000 ₩-5.6bn ₩-7.6bn +₩13.1bn
2026-10-12 ₩106,200 ₩-1.4bn +₩1.6bn ₩-0.3bn
2026-10-08 ₩117,300 ₩-8.1bn +₩5.7bn +₩2.6bn
2026-10-07 ₩122,700 ₩-10.8bn +₩10.6bn +₩0.5bn
2026-10-06 ₩122,600 ₩-9.6bn +₩10.3bn +₩3.5bn
2026-10-02 ₩116,800 ₩-6.4bn +₩3.7bn +₩2.5bn
2026-10-01 ₩116,900 +₩4.2bn +₩19.9bn ₩-23.9bn
2026-09-30 ₩102,500 +₩0.0bn +₩1.9bn ₩-1.9bn
2026-09-29 ₩102,800 ₩-0.9bn ₩-0.7bn +₩1.9bn
2026-09-28 ₩104,400 ₩-2.4bn +₩6.1bn ₩-3.9bn
2026-09-23 ₩102,700 +₩2.4bn ₩-4.5bn +₩2.0bn
2026-09-22 ₩102,200 +₩4.1bn ₩-9.5bn +₩5.6bn
2026-09-21 ₩106,100 +₩12.5bn ₩-7.5bn ₩-3.5bn
2026-09-18 ₩111,600 +₩0.4bn +₩2.8bn ₩-3.0bn
2026-09-17 ₩114,200 ₩-5.5bn +₩4.9bn ₩-0.1bn
2026-09-16 ₩111,100 ₩-8.4bn +₩8.5bn +₩0.1bn
2026-09-15 ₩108,300 +₩2.9bn +₩13.4bn ₩-15.5bn
2026-09-14 ₩100,100 ₩-14.8bn +₩5.3bn +₩9.5bn
2026-09-11 ₩109,300 ₩-1.8bn +₩7.8bn ₩-5.5bn
2026-09-10 ₩99,800 +₩2.3bn ₩-2.0bn +₩0.1bn
2026-09-09 ₩99,200 +₩0.1bn ₩-0.7bn +₩0.5bn
2026-09-08 ₩99,100 +₩4.8bn ₩-3.3bn ₩-1.5bn
2026-09-07 ₩97,500 +₩5.7bn ₩-4.1bn ₩-3.8bn
2026-09-04 ₩95,900 +₩4.9bn +₩0.0bn ₩-4.6bn
2026-09-03 ₩91,800 +₩5.6bn ₩-14.7bn +₩8.9bn
2026-09-02 ₩100,200 +₩1.7bn ₩-9.6bn +₩8.1bn
2026-09-01 ₩105,500 +₩0.8bn ₩-1.6bn +₩0.5bn
2026-08-31 ₩103,400 ₩-0.3bn ₩-2.8bn +₩2.9bn
2026-08-28 ₩105,900 ₩-2.8bn +₩1.1bn +₩1.6bn
2026-08-27 ₩104,800 +₩8.8bn +₩2.2bn ₩-11.0bn
2026-08-26 ₩99,300 ₩-1.3bn ₩-2.5bn +₩4.3bn
2026-08-25 ₩100,400 ₩-0.6bn ₩-0.8bn +₩1.5bn
2026-08-24 ₩102,200 +₩2.5bn +₩1.3bn ₩-3.7bn
2026-08-21 ₩98,100 ₩-11.6bn ₩-6.8bn +₩18.2bn
2026-08-20 ₩109,400 ₩-9.6bn +₩10.1bn ₩-0.5bn
2026-08-19 ₩104,400 ₩-0.8bn ₩-0.3bn +₩1.0bn
2026-08-18 ₩106,500 +₩8.1bn ₩-8.1bn ₩-0.7bn
2026-08-14 ₩112,000 +₩6.1bn ₩-9.3bn +₩2.7bn
2026-08-13 ₩112,500 +₩6.9bn ₩-22.7bn +₩15.8bn
2026-08-12 ₩113,500 ₩-4.2bn ₩-32.9bn +₩37.7bn
2026-08-11 ₩131,900 ₩-4.7bn ₩-7.6bn +₩12.1bn
2026-08-10 ₩137,800 ₩-10.7bn +₩19.0bn ₩-8.8bn
2026-08-07 ₩121,200 ₩-1.1bn +₩0.2bn +₩0.8bn
2026-08-06 ₩123,500 ₩-7.5bn +₩3.1bn +₩4.3bn
2026-08-05 ₩121,500 +₩0.6bn +₩2.1bn ₩-2.8bn
2026-08-04 ₩119,800 ₩-11.7bn +₩20.8bn ₩-9.2bn
2026-08-03 ₩105,400 ₩-1.5bn +₩7.5bn ₩-6.0bn
2026-07-31 ₩94,800 +₩5.9bn ₩-5.9bn +₩0.4bn
2026-07-30 ₩89,500 +₩5.0bn ₩-5.4bn +₩0.4bn
2026-07-29 ₩94,100 +₩4.8bn ₩-9.6bn +₩6.4bn
2026-07-28 ₩107,000 ₩-2.7bn +₩7.6bn ₩-2.7bn
2026-07-27 ₩113,700 ₩-5.6bn +₩9.0bn ₩-3.4bn
2026-07-24 ₩109,500 ₩-3.3bn +₩6.3bn ₩-3.0bn
2026-07-23 ₩113,800 +₩8.0bn ₩-0.5bn ₩-7.8bn
2026-07-22 ₩103,000 +₩10.3bn ₩-10.1bn +₩0.0bn
2026-07-21 ₩109,200 +₩11.0bn ₩-9.4bn ₩-1.6bn
2026-07-20 ₩114,800 ₩-2.8bn ₩-9.4bn +₩12.5bn
2026-07-16 ₩136,600 ₩-6.8bn ₩-5.6bn +₩11.3bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day +₩2.3bn +$2M +₩3.7bn ₩-6.2bn
5 days ₩-6.4bn $-5M ₩-4.7bn +₩10.3bn
20 days ₩-31.9bn $-24M +₩61.2bn ₩-22.7bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying Olix Pharmaceuticals stock?

Over the last 5 sessions foreign investors net sold ₩6.4bn ($5M) of Olix Pharmaceuticals; over 60 sessions they net sold ₩27.3bn ($20M); since Jan 1, 2026 they net sold ₩9.4bn ($7M). Over 20 sessions the stock is the 16th largest foreign net sale among 1828 KOSDAQ stocks.

How much of Olix Pharmaceuticals do foreign investors own?

Foreign investors own 9.49% of Olix Pharmaceuticals' shares as of Oct 16, 2026, versus 6.07% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net bought ₩61.2bn ($45M) and retail investors net sold ₩22.7bn ($17M) of Olix Pharmaceuticals. Institutions are on the other side of foreign selling.

Is Olix Pharmaceuticals listed on KOSPI or KOSDAQ?

Olix Pharmaceuticals (올릭스) trades on KOSDAQ under KRX code 226950 in the Biotech & Pharma group, with a market capitalization of ₩2T ($1.7B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2023 – – -₩18bn (-$14M) -₩19bn (-$14M)
2024 – – -₩31bn (-$23M) -₩41bn (-$30M)
2025 – – -₩30bn (-$22M) -₩16bn (-$12M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1345.9/$) for reference only.

← All foreign investor flows